Adequate intravascular content is mandatory for tissue perfusion.1 Recent multicenter, randomized trials have ddressed the effect of varying levels of vascular content by modifying red blood cells (RBC) and albumin in patients with severe clinical conditions.2-4 Namely, al-bumin in ALBIOS 2 (severe sepsis/septic shock patientsmaintained at 10 /dL hemoglobin; the albumin group had 30 g/L mean serum al-bumin level, the control-crystalloid group had 23 g/L, ame mortality at 28 and 90 days)and SAFE 3 (mix of ICU patients,blood products at the discretion of the clinicians, the albumin group had 30 g/L mean serum albumin level, the control-crystalloid group had 23 g/L, same outcome at 28 days) studies and hemoglobin in TRISS 4 study (septic shock patients, 7 vs. 9 g/dL hemoglobin thresholds for transfusion, same outcome at 28 and 90 days)

Low hemoglobin level with low oncotic pressure in critically ill patients : Is it a safe strategy? / G. Iapichino. - In: MINERVA ANESTESIOLOGICA. - ISSN 1827-1596. - 81:10(2015 Oct), pp. 1047-1049.

Low hemoglobin level with low oncotic pressure in critically ill patients : Is it a safe strategy?

G. Iapichino
Primo
2015

Abstract

Adequate intravascular content is mandatory for tissue perfusion.1 Recent multicenter, randomized trials have ddressed the effect of varying levels of vascular content by modifying red blood cells (RBC) and albumin in patients with severe clinical conditions.2-4 Namely, al-bumin in ALBIOS 2 (severe sepsis/septic shock patientsmaintained at 10 /dL hemoglobin; the albumin group had 30 g/L mean serum al-bumin level, the control-crystalloid group had 23 g/L, ame mortality at 28 and 90 days)and SAFE 3 (mix of ICU patients,blood products at the discretion of the clinicians, the albumin group had 30 g/L mean serum albumin level, the control-crystalloid group had 23 g/L, same outcome at 28 days) studies and hemoglobin in TRISS 4 study (septic shock patients, 7 vs. 9 g/dL hemoglobin thresholds for transfusion, same outcome at 28 and 90 days)
Settore MED/41 - Anestesiologia
ott-2015
http://www.minervamedica.it/it/getpdf/5LvOY0LlUTtLiDowAGGsccTchz8m1CTPeaRbjDNOwgKfcygNUJZcTKe%252Fdgo4VWaYKp3829mRr7%252FcrKf5Ae2CmA%253D%253D/R02Y2015N10A1047.pdf
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/327204
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact